Universal Health Granted New Trial in Nevada Verdict
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Universal Health ( (UHS) ) has issued an announcement.
Universal Health Services reported strong 2025 results, with fourth-quarter net income attributable to UHS rising to $445.9 million, or $7.06 per diluted share, on 9.1% higher net revenues of $4.486 billion versus a year earlier. For the full year 2025, net income climbed to $1.489 billion, or $23.10 per diluted share, on 9.7% revenue growth to $17.365 billion, supported by higher net revenue per adjusted admission and patient day in both its acute care and behavioral health segments and improved EBITDA.
Operationally, same-facility acute care revenues rose 6.9% in the fourth quarter and 8.5% for 2025, while behavioral health revenues increased 7.2% and 7.7% over the same periods, though operating cash flow declined by $203 million year over year to $1.864 billion, mainly due to higher receivables and self-insurance payments. Separately, UHS of Delaware, Inc., an administrative subsidiary, saw a September 26, 2025 jury verdict in Nevada awarding $4.7 million in compensatory and $500 million in punitive damages over physician departures, but on February 25, 2026 the trial judge verbally granted a new trial for juror misconduct, potentially vacating the verdict; the company has reserved $18 million and warns an adverse outcome could materially affect its financial condition.
The most recent analyst rating on (UHS) stock is a Buy with a $258.00 price target. To see the full list of analyst forecasts on Universal Health stock, see the UHS Stock Forecast page.
Spark’s Take on UHS Stock
According to Spark, TipRanks’ AI Analyst, UHS is a Outperform.
UHS scores well on improving profitability and a strengthening balance sheet, supported by favorable technical momentum and a low P/E. The score is tempered by uneven free-cash-flow conversion and earnings-call risks tied to liability reserves/legal items and uncertainty around pending Medicaid-related benefits.
To see Spark’s full report on UHS stock, click here.
More about Universal Health
Universal Health Services, Inc. is a U.S.-based hospital and healthcare services company operating acute care hospitals and behavioral health facilities. The company derives revenues from inpatient and outpatient acute care services and behavioral health care, with a focus on same-facility growth in admissions, patient days and net revenue per admission and patient day across its national network.
Average Trading Volume: 715,002
Technical Sentiment Signal: Buy
Current Market Cap: $14.37B
For detailed information about UHS stock, go to TipRanks’ Stock Analysis page.
